Company GeneMatrix Inc.

Equities

A109820

KR7109820001

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Other Biotechnology & Medical Research

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/06/2024 BST			5-day change	1st Jan Change
2,510 ^KRW	0.00%		+3.08%	-19.16%

2023	GeneMatrix Inc.(KOSDAQ:A109820) dropped from S&P Global BMI Index	CI
2021	GeneMatrix Inc.(KOSDAQ:A109820) added to S&P Global BMI Index	CI

GENEMATRIX Inc. is a Korea-based company mainly engaged in biotechnology business. The Company operates in two segments: pharmaceutical development and diagnostic medicine. Its pharmaceutical development segment specializes in the development of restriction fragment mass polymorphism (RFMP) genotyping technology for diagnosis of hepatitis B virus (HBV), hepatitis C virus (HCV), human papillomavirus (HPV) and others. Its diagnostic medicine segment specializes in the manufacture and sale of liver-function examination reagents, and import and sale of medical equipment and reagents.

Number of employees: 31

KRW in Million	2022	Weight	2023	Weight	Delta
NeoPlex Human Papillomavirus 29 83.2 %	9,787	87.3 %	8,164	83.2 %	-16.58%
Medical Equipment 13.6 %	1,052	9.4 %	1,333	13.6 %	+26.69%
Research Services 3.0 %	361	3.2 %	299	3.0 %	-17.16%
Analysis Services 0.2 %	15	0.1 %	19	0.2 %	+24.51%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 80.9 %	6,010	53.6 %	7,939	80.9 %	+32.09%
South America 6.5 %	-	-	637	6.5 %	-
Europe 4.9 %	871	7.8 %	485	4.9 %	-44.32%
Asia 4.9 %	-	-	482	4.9 %	-
Middle East 2.5 %	3,617	32.3 %	249	2.5 %	-93.11%
Others 0.2 %	716	6.4 %	22	0.2 %	-96.86%

Managers	Title	Age	Since
Soo-Ok Kim CEO	Chief Executive Officer	64	06/12/00
Suk-Joon Kim BRD	Director/Board Member	56	-
Sun-Pyo Hong BRD	Director/Board Member	55	-
Myung-Hoon Lee AUD	Comptroller/Controller/Auditor	57	-

Members of the board	Title	Age	Since
Mahn-Soon Hwang BRD	Director/Board Member	54	-
Soo-Ok Kim CEO	Chief Executive Officer	64	06/12/00
Sun-Pyo Hong BRD	Director/Board Member	55	-
Suk-Joon Kim BRD	Director/Board Member	56	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	20,393,640	16,711,098 ( 81.94 %)	429,477 ( 2.106 %)	81.94 %

Name	Equities	%	Valuation
Soo-Ok Kim 8.673 %	1,768,791	8.673 %	3 M ₩
Suk-Joon Kim 3.426 %	698,700	3.426 %	1 M ₩
DFA Australia Ltd. 0.006198 %	1,264	0.006198 %	2 282 ₩

GENEMATRIX, Inc.

7-8/F, Korea Bio Park Building 700 Daewangpangyo-ro

13488, Seongnam-si

http://www.genematrix.net

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
GENEMATRIX INC.	-19.16%	36.99M
MODERNA, INC.	+40.80%	53.67B
LONZA GROUP AG	+35.45%	38.86B
IQVIA HOLDINGS INC.	-8.05%	38.76B
CELLTRION, INC.	-8.98%	27.27B
ICON PUBLIC LIMITED COMPANY	+10.69%	25.91B
ALNYLAM PHARMACEUTICALS, INC.	-16.21%	20.29B
UNITED THERAPEUTICS CORPORATION	+31.00%	12.78B
MEDPACE HOLDINGS, INC.	+28.51%	12.18B
BIO-TECHNE CORPORATION	-1.67%	11.96B

Other Biotechnology & Medical Research